We obtained high-quality cardiac tissue-like constructs (CTLCs) by cultivating hiPSC-CMs on aligned nanofibers made of biodegradable polymer. We show that multi-layered and elongated CMs could promptly be organized at high density along aligned nanofibers, resulting in upregulated cardiac biomarkers and enhanced cardiac functions. When used for drug assessment, CTLCs were much more robust than the 2D conventional control. We used the CTLCs to simulate the repairing of disconnected and arrhythmia CMs in vitro. When used to repair injured rat hearts, the CTLCs showed excellent operability leading to favorable heart function recovery.
Researchers from the Institute for Integrated Cell-Material Sciences (iCeMS) of Kyoto University and the Department of Cardiovascular Surgery of Osaka University have developed effective and convenient Cardiac Tissue-Like Constructs (CTLCs) for repairing myocardial infarctions.
Cardiovascular diseases such as infarctions are the leading cause of death globally. A seriously injured heart cannot recover by itself, and heart transplants are the only effective treatment. However, the waiting list for transplants is extremely long. Previous researchers have also used cell transplant technologies to repair injured hearts, but these used CMs organized in two dimensions with a random, myofibril structure, which is different from natural heart tissue.
Dr. Li Liu and Prof. Yong Chen of iCeMS, together with Prof. Yoshiki Sawa of Osaka University and colleagues, selected a PLGA material approved by the FDA, and prepared biodegradable, aligned nanofibers for culturing CMs derived from hiPSCs, successfully creating organized and functional CTLCs.
They found that the CMs infiltrated and enveloped the nanofibers, showing elongation and high organization with upregulated expression of cardiac markers. Their CTLCs demonstrated more robust drug response compared with 2D CMs.
The team also used the CTLCs to simulate the repairing of disconnected and arrhythmia CMs. When used to repair injured rat hearts, the CTLCs showed excellent operability leading to favorable heart function recovery.
Future studies are now being planned to use CTLCs to repair injured hearts of larger animals, before advancing to clinical applications.
Learn more: Mending hearts in three dimensions
The Latest on: Repairing myocardial infarctions
- Radovan Borojevic: The tamer of cellson February 20, 2021 at 10:42 am
At nearly 80 years of age, Radovan Borojevic has no complaints about his life. "I have had more opportunities than I was able to take,” says the biologist. “I feel obliged to give back through my work ...
- Hydrogel injection may change the way the heart muscle heals after a heart attackon February 19, 2021 at 9:32 am
Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel that could help ...
- Hydrogel injection could help repair damage to the heart muscle after heart attackon February 19, 2021 at 6:20 am
Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel that could help ...
- First rare heart surgery of the region: 50-year-old with acute heart attack, hole in heart saved successfully in Noidaon February 16, 2021 at 1:55 am
In a first of its kind successful treatment for a rare heart condition in the region of Noida and Greater Noida, doctors at Yatharth Hospital Greater Noida, endured a new lease of life to a ...
- Immunomodulation for optimal cardiac regeneration: insights from comparative analyseson February 15, 2021 at 3:12 am
This review will provide an overview of experimental animal models that have informed our understanding of cardiac repair mechanisms, before focusing on the innate and adaptive immune response to MI.
- Stem Cells in Cardiac Repairon February 10, 2021 at 4:00 pm
Although different stem cells are available for cardiac repair, the optimal stem cell ... transplantation into patients' hearts after myocardial infarction must be investigated systematically ...
- Cell type–specific microRNA therapies for myocardial infarctionon February 10, 2021 at 12:40 pm
Current interventions fail to recover injured myocardium after infarction and prompt the ... to confer beneficial effects on cardiac repair. Intramyocardial injection of MSC-exo containing miR-182 ...
- Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trialon February 2, 2021 at 4:00 pm
The REPAIR-AMI trial is an investigator-initiated ... A total of 200 patients who have suffered an acute myocardial infarction (see below) will be randomized to receive either progenitor cells ...
- An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigson February 2, 2021 at 4:00 pm
1 Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC 27607, USA. 2 Comparative Medicine Institute, North Carolina State University, Raleigh, NC 27607, USA. 3 ...
- Cardiac cell–integrated microneedle patch for treating myocardial infarctionon February 2, 2021 at 4:00 pm
These channels allow regenerative factors secreted by CSCs to be released into the injured myocardium to promote heart repair. In the rat MI model ... as the first instance of a hospitalized ...
via Google News and Bing News
